Senti Biosciences is trading 5.49% lower at $0.24 on October 14, with no specific cause for the decline established by available reporting.
- Shares fell 19.96% at the October 13 close.
- The biotech sector benchmark is down 2.01%, and broader markets are also lower, supporting a risk-off backdrop.
- The company is seeking additional shareholder support for its adjourned merger vote; available reporting does not directly link it to today’s decline.